Our initial data showed that IFN-λ1 mRNA expression and serum protein levels in patients with SLE were higher compared with normal controls, suggesting a role for IFN-λ1 in the pathogenesis of SLE. Here, IFNL1 is linked to systemic lupus erythematosus.